The Prognostic Value of Circulating Tumor DNA in Ovarian Cancer: A Meta-Analysis

Conclusions: The results of our analysis suggested that ctDNA is a potential biomarker that can be used to evaluate the prognosis of patients with ovarian cancer.PMID:34817271 | DOI:10.1177/15330338211043784

Source: Technology in Cancer Research and Treatment - November 24, 2021 Category: Cancer & Oncology Authors: Yuanyuan Lu Li Li Source Type: research